Gene Page: NCL
Summary ?
GeneID | 4691 |
Symbol | NCL |
Synonyms | C23 |
Description | nucleolin |
Reference | MIM:164035|HGNC:HGNC:7667|HPRD:01245| |
Gene type | protein-coding |
Map location | 2q37.1 |
Pascal p-value | 0.062 |
Sherlock p-value | 0.159 |
Fetal beta | 0.246 |
eGene | Meta |
Support | Ascano FMRP targets |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS | |
PMID:cooccur | High-throughput literature-search | Systematic search in PubMed for genes co-occurring with SCZ keywords. A total of 3027 genes were included. | |
Literature | High-throughput literature-search | Co-occurance with Schizophrenia keywords: schizophrenia,schizophrenic,schizophrenics,schizotypy,schizophrenias,schizotypal | Click to show details |
Network | Shortest path distance of core genes in the Human protein-protein interaction network | Contribution to shortest path in PPI network: 0.0143 |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)

Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
AC116610.1 | 1.00 | 1.00 |
ZNHIT1 | 0.87 | 0.75 |
COX8A | 0.86 | 0.75 |
TRAPPC5 | 0.86 | 0.76 |
NDUFB7 | 0.85 | 0.71 |
NDUFA11 | 0.85 | 0.70 |
MRP63 | 0.85 | 0.74 |
C7orf59 | 0.85 | 0.72 |
C19orf70 | 0.85 | 0.75 |
NDUFA2 | 0.84 | 0.73 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
BAT2D1 | -0.44 | -0.41 |
RBM25 | -0.41 | -0.44 |
MYH9 | -0.40 | -0.37 |
ZC3H13 | -0.39 | -0.37 |
UPF2 | -0.38 | -0.34 |
ZNHIT6 | -0.37 | -0.34 |
MACF1 | -0.37 | -0.34 |
SFRS12 | -0.37 | -0.41 |
MDN1 | -0.36 | -0.33 |
SLC6A6 | -0.36 | -0.34 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0000166 | nucleotide binding | IEA | - | |
GO:0003676 | nucleic acid binding | IEA | - | |
GO:0003677 | DNA binding | IEA | - | |
GO:0003723 | RNA binding | TAS | 2737305 | |
GO:0005515 | protein binding | IEA | - | |
GO:0008022 | protein C-terminus binding | IPI | 16403913 | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0001525 | angiogenesis | IDA | 16403913 | |
Cellular component | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0005634 | nucleus | IEA | - | |
GO:0005730 | nucleolus | IDA | 12944467 | |
GO:0005730 | nucleolus | IEA | - | |
GO:0005938 | cell cortex | IDA | 16403913 |
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ADAP1 | CENTA1 | GCS1L | p42IP4 | ArfGAP with dual PH domains 1 | - | HPRD,BioGRID | 12565890 |
CD3E | FLJ18683 | T3E | TCRE | CD3e molecule, epsilon (CD3-TCR complex) | Reconstituted Complex | BioGRID | 11115514 |
CSNK2A1 | CK2A1 | CKII | casein kinase 2, alpha 1 polypeptide | - | HPRD | 2192260|8663258 |
CSNK2A2 | CK2A2 | CSNK2A1 | FLJ43934 | casein kinase 2, alpha prime polypeptide | Affinity Capture-Western Biochemical Activity Far Western | BioGRID | 8663258 |
CYFIP1 | FLJ45151 | P140SRA-1 | SHYC | SRA1 | cytoplasmic FMR1 interacting protein 1 | Affinity Capture-Western | BioGRID | 11438699 |
FMR1 | FMRP | FRAXA | MGC87458 | POF | POF1 | fragile X mental retardation 1 | Affinity Capture-Western | BioGRID | 10567518 |
GZMA | CTLA3 | HFSP | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | - | HPRD | 1860869 |
MDK | FLJ27379 | MK | NEGF2 | midkine (neurite growth-promoting factor 2) | - | HPRD,BioGRID | 12147681 |
MYB | Cmyb | c-myb | c-myb_CDS | efg | v-myb myeloblastosis viral oncogene homolog (avian) | Affinity Capture-Western | BioGRID | 10660576 |
MYBL1 | A-MYB | AMYB | MGC120059 | MGC120061 | v-myb myeloblastosis viral oncogene homolog (avian)-like 1 | Affinity Capture-Western Far Western | BioGRID | 10660576 |
MYC | bHLHe39 | c-Myc | v-myc myelocytomatosis viral oncogene homolog (avian) | Ncl (nucleolin) interacts with Myc (c-Myc). | BIND | 15674325 |
NPM1 | B23 | MGC104254 | NPM | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | - | HPRD,BioGRID | 8620867 |10503877 |
NR3C1 | GCCR | GCR | GR | GRL | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | - | HPRD,BioGRID | 8530516 |11162542 |
PPARGC1A | LEM6 | PGC-1(alpha) | PGC-1v | PGC1 | PGC1A | PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | - | HPRD | 10983978 |
PPP1CB | MGC3672 | PP-1B | PPP1CD | protein phosphatase 1, catalytic subunit, beta isoform | Affinity Capture-Western | BioGRID | 12185196 |
PRKCZ | PKC-ZETA | PKC2 | protein kinase C, zeta | - | HPRD,BioGRID | 9388266 |
S100A11 | MLN70 | S100C | S100 calcium binding protein A11 | - | HPRD,BioGRID | 14623863 |
SFRS12 | DKFZp564B176 | MGC133045 | SRrp508 | SRrp86 | splicing factor, arginine/serine-rich 12 | - | HPRD | 14559993 |
SP1 | - | Sp1 transcription factor | Affinity Capture-Western | BioGRID | 14623863 |
SSB | LARP3 | La | Sjogren syndrome antigen B (autoantigen La) | Affinity Capture-MS Affinity Capture-Western | BioGRID | 12096904 |
SWAP70 | FLJ39540 | HSPC321 | KIAA0640 | SWAP-70 | SWAP-70 protein | - | HPRD,BioGRID | 9642267 |
TERT | EST2 | TCS1 | TP2 | TRT | hEST2 | telomerase reverse transcriptase | Affinity Capture-Western Reconstituted Complex | BioGRID | 15371412 |
TERT | EST2 | TCS1 | TP2 | TRT | hEST2 | telomerase reverse transcriptase | nucleolin interacts with hTERT. | BIND | 15371412 |
TOP1 | TOPI | topoisomerase (DNA) I | Top1 interacts with Nucleolin | BIND | 10967121 |
TOP1 | TOPI | topoisomerase (DNA) I | - | HPRD,BioGRID | 8567649 |9512561 |10967121 |
TP53 | FLJ92943 | LFS1 | TRP53 | p53 | tumor protein p53 | - | HPRD,BioGRID | 12138209 |
TROVE2 | RO60 | SSA2 | TROVE domain family, member 2 | - | HPRD | 12096904 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
KEGG PATHOGENIC ESCHERICHIA COLI INFECTION | 59 | 36 | All SZGR 2.0 genes in this pathway |
BIOCARTA SARS PATHWAY | 10 | 5 | All SZGR 2.0 genes in this pathway |
PID AURORA B PATHWAY | 39 | 24 | All SZGR 2.0 genes in this pathway |
PID MYC ACTIV PATHWAY | 79 | 62 | All SZGR 2.0 genes in this pathway |
PID TELOMERASE PATHWAY | 68 | 48 | All SZGR 2.0 genes in this pathway |
PID UPA UPAR PATHWAY | 42 | 30 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY SERUM DEPRIVATION UP | 552 | 347 | All SZGR 2.0 genes in this pathway |
GRAESSMANN RESPONSE TO MC AND SERUM DEPRIVATION UP | 211 | 136 | All SZGR 2.0 genes in this pathway |
CAIRO PML TARGETS BOUND BY MYC UP | 23 | 17 | All SZGR 2.0 genes in this pathway |
HAMAI APOPTOSIS VIA TRAIL UP | 584 | 356 | All SZGR 2.0 genes in this pathway |
DARWICHE SKIN TUMOR PROMOTER UP | 142 | 96 | All SZGR 2.0 genes in this pathway |
DARWICHE PAPILLOMA RISK LOW UP | 162 | 104 | All SZGR 2.0 genes in this pathway |
DARWICHE PAPILLOMA RISK HIGH UP | 147 | 101 | All SZGR 2.0 genes in this pathway |
DARWICHE SQUAMOUS CELL CARCINOMA UP | 146 | 104 | All SZGR 2.0 genes in this pathway |
SCHLOSSER MYC TARGETS AND SERUM RESPONSE DN | 47 | 34 | All SZGR 2.0 genes in this pathway |
MARTORIATI MDM4 TARGETS FETAL LIVER DN | 514 | 319 | All SZGR 2.0 genes in this pathway |
KIM MYC AMPLIFICATION TARGETS UP | 201 | 127 | All SZGR 2.0 genes in this pathway |
HATADA METHYLATED IN LUNG CANCER UP | 390 | 236 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA1 PCC NETWORK | 1652 | 1023 | All SZGR 2.0 genes in this pathway |
PUJANA ATM PCC NETWORK | 1442 | 892 | All SZGR 2.0 genes in this pathway |
PUJANA CHEK2 PCC NETWORK | 779 | 480 | All SZGR 2.0 genes in this pathway |
RICKMAN METASTASIS UP | 344 | 180 | All SZGR 2.0 genes in this pathway |
SCHAEFFER PROSTATE DEVELOPMENT 6HR UP | 176 | 115 | All SZGR 2.0 genes in this pathway |
DEN INTERACT WITH LCA5 | 26 | 21 | All SZGR 2.0 genes in this pathway |
BENPORATH MYC TARGETS WITH EBOX | 230 | 156 | All SZGR 2.0 genes in this pathway |
BENPORATH MYC MAX TARGETS | 775 | 494 | All SZGR 2.0 genes in this pathway |
MENSSEN MYC TARGETS | 53 | 35 | All SZGR 2.0 genes in this pathway |
PENG LEUCINE DEPRIVATION DN | 187 | 122 | All SZGR 2.0 genes in this pathway |
COLLER MYC TARGETS UP | 25 | 19 | All SZGR 2.0 genes in this pathway |
PENG GLUTAMINE DEPRIVATION DN | 337 | 230 | All SZGR 2.0 genes in this pathway |
MATSUDA NATURAL KILLER DIFFERENTIATION | 475 | 313 | All SZGR 2.0 genes in this pathway |
BROWN MYELOID CELL DEVELOPMENT DN | 129 | 86 | All SZGR 2.0 genes in this pathway |
HESS TARGETS OF HOXA9 AND MEIS1 UP | 65 | 44 | All SZGR 2.0 genes in this pathway |
MA MYELOID DIFFERENTIATION UP | 39 | 29 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS EARLY PROGENITOR | 532 | 309 | All SZGR 2.0 genes in this pathway |
JOSEPH RESPONSE TO SODIUM BUTYRATE DN | 64 | 45 | All SZGR 2.0 genes in this pathway |
ZHOU TNF SIGNALING 4HR | 54 | 36 | All SZGR 2.0 genes in this pathway |
HU GENOTOXIN ACTION DIRECT VS INDIRECT 24HR | 55 | 38 | All SZGR 2.0 genes in this pathway |
JIANG HYPOXIA NORMAL | 311 | 205 | All SZGR 2.0 genes in this pathway |
JIANG AGING CEREBRAL CORTEX DN | 54 | 43 | All SZGR 2.0 genes in this pathway |
BILD MYC ONCOGENIC SIGNATURE | 206 | 117 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 6HR DN | 911 | 527 | All SZGR 2.0 genes in this pathway |
KRIGE RESPONSE TO TOSEDOSTAT 24HR DN | 1011 | 592 | All SZGR 2.0 genes in this pathway |
RIZKI TUMOR INVASIVENESS 2D UP | 69 | 46 | All SZGR 2.0 genes in this pathway |
GRADE COLON CANCER UP | 871 | 505 | All SZGR 2.0 genes in this pathway |
MUELLER PLURINET | 299 | 189 | All SZGR 2.0 genes in this pathway |
BOYLAN MULTIPLE MYELOMA C D UP | 139 | 95 | All SZGR 2.0 genes in this pathway |
SWEET LUNG CANCER KRAS UP | 491 | 316 | All SZGR 2.0 genes in this pathway |
HSIAO HOUSEKEEPING GENES | 389 | 245 | All SZGR 2.0 genes in this pathway |
MILI PSEUDOPODIA CHEMOTAXIS UP | 74 | 45 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA CLASSES UP | 605 | 377 | All SZGR 2.0 genes in this pathway |
DANG MYC TARGETS UP | 143 | 100 | All SZGR 2.0 genes in this pathway |
DANG BOUND BY MYC | 1103 | 714 | All SZGR 2.0 genes in this pathway |
WONG EMBRYONIC STEM CELL CORE | 335 | 193 | All SZGR 2.0 genes in this pathway |
KIM ALL DISORDERS OLIGODENDROCYTE NUMBER CORR UP | 756 | 494 | All SZGR 2.0 genes in this pathway |
KIM BIPOLAR DISORDER OLIGODENDROCYTE DENSITY CORR UP | 682 | 440 | All SZGR 2.0 genes in this pathway |
FEVR CTNNB1 TARGETS DN | 553 | 343 | All SZGR 2.0 genes in this pathway |
GOBERT OLIGODENDROCYTE DIFFERENTIATION UP | 570 | 339 | All SZGR 2.0 genes in this pathway |
IKEDA MIR1 TARGETS UP | 53 | 39 | All SZGR 2.0 genes in this pathway |
Section VI. microRNA annotation
miRNA family | Target position | miRNA ID | miRNA seq | ||
---|---|---|---|---|---|
UTR start | UTR end | Match method | |||
miR-1/206 | 90 | 97 | 1A,m8 | hsa-miR-1 | UGGAAUGUAAAGAAGUAUGUA |
hsa-miR-206SZ | UGGAAUGUAAGGAAGUGUGUGG | ||||
hsa-miR-613 | AGGAAUGUUCCUUCUUUGCC | ||||
miR-194 | 57 | 63 | m8 | hsa-miR-194 | UGUAACAGCAACUCCAUGUGGA |
miR-431 | 96 | 102 | 1A | hsa-miR-431 | UGUCUUGCAGGCCGUCAUGCA |
- SZ: miRNAs which differentially expressed in brain cortex of schizophrenia patients comparing with control samples using microarray. Click here to see the list of SZ related miRNAs.
- Brain: miRNAs which are expressed in brain based on miRNA microarray expression studies. Click here to see the list of brain related miRNAs.